Compartmentalization of Hepatitis C Virus (HCV) during HCV/HIV coinfection

Journal of Infectious Diseases

Volumn 195, Issue 12, 2007, Pages 1765-1773

  Blackard, Jason T ^a,b   Hiasa, Yoichi ^g   Smeaton, Laura ^c   Jamieson, Denise J ^d   Rodriguez, Irma ^e   Mayer, Kenneth H ^e,f   Chung, Raymond T ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e MIRIAM HOSPITAL   (United States)

^f BROWN UNIVERSITY   (United States)

^g EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; AMINO ACID SEQUENCE; DNA PRIMERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRUS REPLICATION;

EID: 34249910052     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518251     Document Type: Article

References (40)

1. Sherman K, Rouster S, Chung R, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials groups. Clin Infect Dis 2002; 34:831-7.
2. Sulkowski M, Thomas D. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207.
3. Chung R, Andersen J, Volberding P, et al. Peginterferon alpha-2a plus ribavirin versus interferon alpha-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351:451-9.
4. Perez-Olmeda M, Nunez M, Romero M, et al. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 2003; 17:1023-8.
5. Torriani F, Rodriguez-Torres M, Rockstroh J, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438-50.
6. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44:15-22.
7. Pham T, MacParland S, Mulrooney P, Cooksley H, Naoumov N, Michalak T. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78:5867-74.
8. Radkowski M, Gallegos-Orozco J, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41:106-14.
9. Watkins-Riedel T, Ferenci P, Steindl-Munda P, Gschwantler M, Mueller C, Woegerbauer M. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis. Clin Infect Dis 2004; 39:1754-60.
10. Saleh M, Tibbs C, Koskinas J, et al. Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology 1994; 20:1399-404.
11. Gong G, Lai L, Jiang Y, He Y, Su X. HCV replication in PBMC and its influence on interferon therapy. World J Gasterenterol 2003; 9:291-4.
12. Taliani G, Badolato M, Lecce R, et al. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. J Med Virol 1995; 47:16-22.
13. Boisvert J, He X, Cheung R, Kceffe E, Wright T, Greenberg H. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 2001; 184:827-35.
14. Lin L, Fevery J, Yap S. A novel strand-specific RT-PCR for detection of hepatitis C virus negative-strand RNA (replicative intermediate): evidence of absence or very low level of HCV replication in peripheral blood mononuclear cells. J Virol Methods 2002; 100:97-105.
15. Lerat H, Berby F, Trabaud MA, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97:845-51.
16. Laskus T, Radkowski M, Wang L, Cianciara J, Vargas H, Rakela J. Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. J Gen Virol 1997; 78:2747-50.
17. Kao J, Chen P, Lai M, Wang T, Chen D. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: no correlation with viral genotypes 1b, 2a, and 2b. J Med Virol 1997; 52:270-4.
18. Roque-Afonso A, Jiang J, Penin F, et al. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999; 73:9213-21.
19. Laskus T, Radkowski M, Wang L, Nowicki M, Rakela J. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 2000; 74:1014-7.
20. Roque-Afonso A, Ducoulombier D, Di Liberto G, et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79:6349-57.
21. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 1999; 29:217-22.
22. Maggi F, Fornai C, Morrica A, et al. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol 1999; 57:57-63.
23. Navas S, Martin J, Quiroga J, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998; 72:1640-6.
24. Maggi F, Fornai C, Vatteroni M, et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997; 78:1521-5.
25. Smith D, Warrne D, Vlahov D, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146:459-69.
26. Thomas D, Rich J, Schuman P, et al. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis 2001; 183:973-6.
27. Winters MA, Welles SL, Holodniy M. Hepatitis C virus protease gene diversity in patients coinfected with human immunodeficiency virus. J Virol 2006; 80:4196-9.
28. Roque-Afonso A, Robain M, Simoneau D, et al. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J Infect Dis 2002; 185:728-33.
29. Blackard J, Smeaton L, Hiasa Y, et al. Detection of hepatitis C virus (HCV) in scrum and peripheral blood mononuclear cells of HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis 2005; 192:258-65.
30. Torres-Puente M, Bracho M, Jiminez N, Garcia-Robles I, Moya A, Gonzalez-Candelas F. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol 2003; 84:2343-50.
31. Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D. The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4876-82.
32. Kumar S, Tamura K, Jakobsen I, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001; 17:1244-5.
33. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39:783-91.
34. Wolinksy S, Korber B, Neumann A, et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996; 272:537-42.
35. Korber B, Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 1992; 8:1549-60.
36. Ray S, Wang Y, Laeyendecker O, Ticehurst J, Villano S, Thomas D. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 1999; 73:2938-46.
37. Blackard J, Yang Y, Bordoni P, et al. Hepatitis C virus (HCV) diversity in HIV-HCV coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis 2004; 189:1472-81.
38. Laskus T, Radkowski M, Wang L, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28:1398-401.
39. Lerat H, Rumin S, Habersetzer F, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998; 91:3841-9.
40. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187:1951-8.